Ocugen to file for full US approval of COVID-19 shot Covaxin instead of EUA
Ocugen Inc said on Thursday it would no longer pursue an emergency use authorization for its COVID-19 vaccine candidate, Covaxin, and would instead aim to file for a full U.S. approval of the shot. Ocugen said the decision was based on a recommendation from the U.S. Food and Drug Administration (FDA), which also requested more
Ocugen to file for full US approval of COVID-19 shot Covaxin instead of EUA Read More »




